Steris (STE) Other Non-Current Liabilities (2018 - 2026)
Steris (STE) posted Other Non-Current Liabilities of $75.2 million for Q2 2026, up 4.88% on a QoQ basis from $71.7 million in Q1 2026, and up 18.24% year-over-year from $63.6 million in Q2 2025.
Analysis
Steris (STE) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends
Steris has reported Other Non-Current Liabilities for 9 years, with the latest figure at $75.2 million in Q2 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 18.24% year-over-year to $75.2 million in Q2 2026; TTM through Jun 2026 was $75.2 million, a 18.24% increase from a year earlier, with the FY2026 full-year figure at $71.7 million, up 15.83% from the prior year.
- Other Non-Current Liabilities was $75.2 million for Q2 2026 at Steris, up from $71.7 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $78.4 million in Q4 2023, with the low at $61.9 million in Q1 2025.
- Average Other Non-Current Liabilities over 5 years is $72.2 million, with a median of $73.1 million recorded in 2022.
- The sharpest annual moves came in 2022 and 2026: Other Non-Current Liabilities slipped 15.07% in 2022, then advanced 18.24% in 2026.
- Over 5 years, Other Non-Current Liabilities stood at $72.7 million in 2022, then increased by 7.76% to $78.4 million in 2023, then dropped by 6.71% to $73.1 million in 2024, then fell by 7.83% to $67.4 million in 2025, then gained by 11.57% to $75.2 million in 2026.
- The last three Other Non-Current Liabilities figures came in at $75.2 million (Q2 2026), $71.7 million (Q1 2026), and $67.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 18.23 Bn | 17.82 Bn | 1.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.20 Mn |
| Mar 31, 2026 | 71.70 Mn |
| Dec 31, 2025 | 67.40 Mn |
| Sep 30, 2025 | 63.90 Mn |
| Jun 30, 2025 | 63.60 Mn |
| Mar 31, 2025 | 61.90 Mn |
| Dec 31, 2024 | 73.13 Mn |
| Sep 30, 2024 | 74.15 Mn |
| Jun 30, 2024 | 72.37 Mn |
| Mar 31, 2024 | 71.55 Mn |
| Dec 31, 2023 | 78.39 Mn |
| Sep 30, 2023 | 76.55 Mn |
| Jun 30, 2023 | 76.60 Mn |
| Mar 31, 2023 | 76.14 Mn |
| Dec 31, 2022 | 72.75 Mn |
| Sep 30, 2022 | 75.90 Mn |
| Jun 30, 2022 | 73.08 Mn |
| Mar 31, 2022 | 75.58 Mn |
| Dec 31, 2021 | 74.76 Mn |
| Sep 30, 2021 | 83.59 Mn |